![Manfred Zoltobrocki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Manfred Zoltobrocki
Corporate Officer/Principal at Lux Biosciences, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Paul Chaney | M | 66 |
Lux Biosciences, Inc.
![]() Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | - |
David Guyer | M | 64 |
Lux Biosciences, Inc.
![]() Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | 18 years |
Thomas Dyrberg | M | 69 |
Lux Biosciences, Inc.
![]() Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | - |
Ágnes Gál | F | - |
Aventis Pharma AG
| 22 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Richard Markham | M | 73 |
Aventis Pharma AG
| 3 years |
José Geraldo Ramalho Barella | M | 68 |
Aventis Pharma AG
| - |
Matthias Zachert | M | 56 |
Aventis Pharma AG
| 3 years |
Andreas Busch | M | 59 |
Aventis Pharma AG
| 6 years |
Jürgen Götz | M | 60 |
Aventis Pharma AG
| 5 years |
Marie Paule Richard | M | 72 |
Aventis Pharma AG
| 4 years |
Daniel Pascheles | M | - |
Aventis Pharma AG
| 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
Germany | 8 | 72.73% |
United States | 3 | 27.27% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Manfred Zoltobrocki
- Personal Network